Skip to main content
. Author manuscript; available in PMC: 2020 Oct 9.
Published in final edited form as: Circ Arrhythm Electrophysiol. 2019 Oct 9;12(10):e005557. doi: 10.1161/CIRCEP.117.005557

Figure 4: Effect of ranolazine on DF in tachypacing-induced persistent AF on the LA epicardium from perfused hearts.

Figure 4:

(A) Time course of maximal dominant frequency (DF) during persistent AF in 9 sheep hearts. Continuous ranolazine perfusion (10 μM) begins at time 0 (dashed line). (B) Average DF was decreased during ranolazine perfusion (*p<0.01). (C) Representative DF maps of the LA epicardium before (left) and during (right) perfusion of ranolazine.